Analytical Data
-
Gene name
Galanin
- Application
-
Alternative Names
GALN; GLNN; GMAP; Galanin Prepropeptide; Galanin-Message-Associated Peptide
-
Species
Rat
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 97% as determined by SDS-PAGE.
-
Uniprot
P10683
-
Expression Region
Met26~Leu121
-
Protein Length
Partial
-
Molecular Weight
44kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Galanin is a neuropeptide that plays a crucial role in various physiological processes, including modulation of neurotransmission, neuroendocrine functions, and pain perception. Its actions are mediated through three distinct G-protein-coupled receptors (GALR1, GALR2, GALR3), each of which exhibits different tissue distributions and functional responses. Given its involvement in numerous neurological and psychiatric disorders, such as anxiety, depression, and neurodegeneration, the study of galanin and its receptors has gained significant attention in the scientific community. Researchers have focused on recombinant protein technology to produce galanin and its receptor variants for in-depth biochemical and pharmacological characterization. This approach allows for the exploration of galanin's molecular mechanisms and its potential therapeutic applications. Moreover, studies involving recombinant galanin proteins contribute to understanding ligand-receptor interactions, signaling pathways, and the development of targeted drugs. As a result, galanin recombinant proteins are critical tools for advancing our knowledge in neurosciences and translating basic research findings into clinical therapies.
